Tirzepatide represents a groundbreaking treatment agent for individuals facing type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://ronaldoyxb128912.madmouseblog.com/21285165/tirzepatide-a-game-changer-for-type-2-diabetes